Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob George

Showing results (51-60 of 970) with videos related to

Pageof 97
Sort By:
Lung India : Official Organ of Indian Chest Society|August 25, 2012
Spontaneous pneumomediastinum with a classical radiological signRamakant Dixit, Jacob George
Trends in Endocrinology and Metabolism: TEM|April 11, 2015
Ltb4r1 inhibitor: A pivotal insulin sensitizer?Saeed Esmaili, Jacob George
Nature Reviews. Gastroenterology & Hepatology|October 24, 2019
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biologyMohammed Eslam, Jacob George
Seminars in Liver Disease|September 18, 2015
Nonalcoholic Fatty Liver Disease Management: Dietary and Lifestyle ModificationsVi Nguyen, Jacob George
Hepatology (Baltimore, Md.)|April 30, 2009
Adipocyte-hepatocyte crosstalk and the pathogenesis of nonalcoholic fatty liver diseaseBriohny Smith, Jacob George
Handbook of Experimental Pharmacology|August 14, 2020
Xanthine Oxidoreductase InhibitorsKeeran Vickneson, Jacob George
Expert Review of Cardiovascular Therapy|October 4, 2012
Circulating endothelial cells, plaque rupture and acute coronary syndromesSara Shimoni, Jacob George
JHEP Reports : Innovation in Hepatology|May 28, 2026
ANTICIPATE-ing a future without liver biopsy in MASH. Ready for prime time?Harendran Elangovan, Jacob George
Journal of Hepatology|January 3, 2022
Metabolic and genetic contributions to NAFLD: Really distinct and homogeneous?Elizabeth K Speliotes, Jacob George
Expert Opinion on Pharmacotherapy|November 16, 2007
Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failureJacob George, Allan D Struthers
Pageof 97

Showing results (51-60 of 970) with videos related to

Sort By:
Pageof 97
Lung India : Official Organ of Indian Chest Society|August 25, 2012
Spontaneous pneumomediastinum with a classical radiological signRamakant Dixit, Jacob George
Trends in Endocrinology and Metabolism: TEM|April 11, 2015
Ltb4r1 inhibitor: A pivotal insulin sensitizer?Saeed Esmaili, Jacob George
Nature Reviews. Gastroenterology & Hepatology|October 24, 2019
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biologyMohammed Eslam, Jacob George
Seminars in Liver Disease|September 18, 2015
Nonalcoholic Fatty Liver Disease Management: Dietary and Lifestyle ModificationsVi Nguyen, Jacob George
Hepatology (Baltimore, Md.)|April 30, 2009
Adipocyte-hepatocyte crosstalk and the pathogenesis of nonalcoholic fatty liver diseaseBriohny Smith, Jacob George
Handbook of Experimental Pharmacology|August 14, 2020
Xanthine Oxidoreductase InhibitorsKeeran Vickneson, Jacob George
Expert Review of Cardiovascular Therapy|October 4, 2012
Circulating endothelial cells, plaque rupture and acute coronary syndromesSara Shimoni, Jacob George
JHEP Reports : Innovation in Hepatology|May 28, 2026
ANTICIPATE-ing a future without liver biopsy in MASH. Ready for prime time?Harendran Elangovan, Jacob George
Journal of Hepatology|January 3, 2022
Metabolic and genetic contributions to NAFLD: Really distinct and homogeneous?Elizabeth K Speliotes, Jacob George
Expert Opinion on Pharmacotherapy|November 16, 2007
Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failureJacob George, Allan D Struthers
Pageof 97